The test for this vaccine, BCG, will be carried out with 4,000 hospital workers to verify their ability to reduce the symptoms of covid-19, researchers at the Murdoch Institute in Melbourne said.
“Although it was originally developed against tuberculosis and is still administered to more than 130 million babies every year, BCG also increases the body’s basic immune capacity, helping it to respond to germs more strongly,” explained the researchers. in a statement.
“We hope that there will be a reduction in the frequency and severity of Covid-19 symptoms for health personnel who have been vaccinated with BCG,” explained team leader Nigel Curtis.
Similar tests will be carried out in other countries, such as the Netherlands, Germany and the United Kingdom.